Caricamento...
The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
BACKGROUND: Treatment with disease-modifying anti-rheumatic drugs (DMARDs) has raised concerns about the risk of malignancies in rheumatoid arthritis (RA) patients. However, the association between biologic DMARDs (bDMARDs) and malignancy in previous reports remains controversial. Therefore we aimed...
Salvato in:
| Pubblicato in: | Arthritis Res Ther |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5732524/ https://ncbi.nlm.nih.gov/pubmed/29246243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1482-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|